European equities traded in the US as American depositary receipts kicked off the week on a down note Monday morning, falling 0.87% to 1,321.99 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biotech firm BioNTech (BNTX), which rose 3.3% and 2.7% respectively. They were followed by telecommunication companies Ericsson (ERIC) and Telefonica (TEF) and, which were up 1.1% and 0.7% respectively.
The decliners from continental Europe were led by accommodations booking company trivago (TRVG) and semiconductor company Sequans Communications (SQNS), which lost 9.5% and 4.7% respectively. They were followed by 3D printer company Materialise (MTLS) and internet browser company Opera (OPRA), which dropped 4% and 3.2% respectively.
From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which advanced 4.2% and 3.2% respectively. They were followed by biopharmaceutical companies Verona Pharma (VRNA) and Mereo BioPharma Group (MREO), which rose 3.9% and 3.5% respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company NuCana (NCNA), which fell 4.5% and 3.8% respectively. They were followed by cruise line operator Carnival (CUK) and biotech firm Trinity Biotech (TRIB), which were down 3% and 2.3% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。